Streetwise Reports
The Gold Report
The Energy Report
The Life Sciences Report
Research Reports
Streetwise Reports
The Gold Report
The Energy Report
The Life Sciences Report
Research Reports
Articles
Agriculture
Alternative - Biofuels
Alternative - Cleantech
Alternative Energy
Base Metals
Battery Metals
Biotechnology / Pharmaceuticals
Cannabis
Clean Energy
Coal
Cobalt / Lithium / Manganese
Critical Metals
Cryptocurrency / Blockchain
Gold
Healthcare Services
Helium
Life Sciences Tools & Diagnostics
Medical Devices
Oil & Gas - Exploration & Production
Oil & Gas - Services
PGM - Platinum Group Metals
Regenerative Medicine
Renewable - Geothermal
Renewable - Solar
Renewable - Wind
Silver
Special Situations
Technology
Uranium
Disclosures
Nektar Therapeutics
NKTR:NASDAQ
Streetwise Company Fact Sheet
2024/11/4 21:29:38
(NKTR:NASDAQ)
Analyst coverage
J.P. Morgan
—
Jessica Fye
William Blair
—
Andy Hsieh
Oppenheimer & Co.
—
Jay Olson
Goldman Sachs
—
Chris Shibutani
Jefferies & Co.
—
Roger Song
Newsletter coverage
Ron Struthers
—
Struthers Resource Stock Report
Streetwise Reports Articles
10/22/2024 - View Article
04/15/2024 - View Article
03/27/2024 - View Article
02/12/2024 - View Article
Streetwise - Nektar Therapeutics Ownership Overview*
Nektar Therapeutics
(NKTR:NASDAQ)
*
Share Structure as of 3/27/2024